Does LORLATINIB Cause Blindness? 19 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 19 reports of Blindness have been filed in association with LORLATINIB (Lorbrena). This represents 0.3% of all adverse event reports for LORLATINIB.
19
Reports of Blindness with LORLATINIB
0.3%
of all LORLATINIB reports
4
Deaths
2
Hospitalizations
How Dangerous Is Blindness From LORLATINIB?
Of the 19 reports, 4 (21.1%) resulted in death, 2 (10.5%) required hospitalization, and 2 (10.5%) were considered life-threatening.
Is Blindness Listed in the Official Label?
Yes, Blindness is listed as a known adverse reaction in the official FDA drug label for LORLATINIB.
What Other Side Effects Does LORLATINIB Cause?
Death (1,050)
Neoplasm progression (633)
Off label use (394)
Weight increased (306)
Hallucination (290)
Blood cholesterol increased (281)
Dyspnoea (223)
Oedema peripheral (198)
Oedema (195)
Fatigue (188)
What Other Drugs Cause Blindness?
ADALIMUMAB (1,599)
AFLIBERCEPT (1,337)
BEVACIZUMAB (847)
INSULIN GLARGINE (837)
APIXABAN (789)
INSULIN LISPRO (760)
RANIBIZUMAB (760)
ETANERCEPT (669)
PREGABALIN (646)
ESOMEPRAZOLE (617)
Which LORLATINIB Alternatives Have Lower Blindness Risk?
LORLATINIB vs LORMETAZEPAM
LORLATINIB vs LORNOXICAM
LORLATINIB vs LOSARTAN
LORLATINIB vs LOSARTAN\LOSARTAN
LORLATINIB vs LOTEPREDNOL ETABONATE